Joshua H. DeRienzis - 07 May 2022 Form 4 Insider Report for SURGALIGN HOLDINGS, INC.

Reporting relationship: Chief Legal Officer
Issuer ticker: N/A
Reported as of: 07 May 2022
Net transaction value: -$3,333
SEC form: 4
Accepted by SEC: 10 May 2022, 15:01:17 UTC
Prior SEC filing: 11 Apr 2022
Source filing: View source filing
Reporting owner signature: By Jessica Rumschlag as attorney in fact

Key filing fact

Joshua H. DeRienzis filed Form 4 for SURGALIGN HOLDINGS, INC. on 10 May 2022.

Key facts

This page summarizes Joshua H. DeRienzis's Form 4 filing for SURGALIGN HOLDINGS, INC..
3 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 10 May 2022, 15:01.

Change

Previous filing in this sequence was filed on 11 Apr 2022.
Current net transaction value: -$3,333.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SRGA transaction

Common Stock

Tax liability

Transaction value: $369
Shares: -2,019
Change %: -0.43%
Price: $0.1830
Shares after: 471,785
Date: 07 May 2022
Ownership: Direct
Footnotes: F1

SRGA transaction

Common Stock

Tax liability

Transaction value: $1,555
Shares: -8,498
Change %: -1.8%
Price: $0.1830
Shares after: 463,287
Date: 07 May 2022
Ownership: Direct
Footnotes: F1

SRGA transaction

Common Stock

Tax liability

Transaction value: $1,409
Shares: -7,698
Change %: -1.7%
Price: $0.1830
Shares after: 455,589
Date: 07 May 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Shares withheld by Surgalign Holdings, Inc. to satisfy the withholding obligation in connection with the vesting of previously awarded restricted stock.